BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 25904541)

  • 1. Enhanced Classification of Brugada Syndrome-Associated and Long-QT Syndrome-Associated Genetic Variants in the SCN5A-Encoded Na(v)1.5 Cardiac Sodium Channel.
    Kapplinger JD; Giudicessi JR; Ye D; Tester DJ; Callis TE; Valdivia CR; Makielski JC; Wilde AA; Ackerman MJ
    Circ Cardiovasc Genet; 2015 Aug; 8(4):582-95. PubMed ID: 25904541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phylogenetic and physicochemical analyses enhance the classification of rare nonsynonymous single nucleotide variants in type 1 and 2 long-QT syndrome.
    Giudicessi JR; Kapplinger JD; Tester DJ; Alders M; Salisbury BA; Wilde AA; Ackerman MJ
    Circ Cardiovasc Genet; 2012 Oct; 5(5):519-28. PubMed ID: 22949429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect.
    Veltmann C; Barajas-Martinez H; Wolpert C; Borggrefe M; Schimpf R; Pfeiffer R; Cáceres G; Burashnikov E; Antzelevitch C; Hu D
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long QT and Brugada syndrome gene mutations in New Zealand.
    Chung SK; MacCormick JM; McCulley CH; Crawford J; Eddy CA; Mitchell EA; Shelling AN; French JK; Skinner JR; Rees MI
    Heart Rhythm; 2007 Oct; 4(10):1306-14. PubMed ID: 17905336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the predictive accuracy of five in silico prediction tools, alone or in combination, and two metaservers to classify long QT syndrome gene mutations.
    Leong IU; Stuckey A; Lai D; Skinner JR; Love DR
    BMC Med Genet; 2015 May; 16():34. PubMed ID: 25967940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants.
    Kapa S; Tester DJ; Salisbury BA; Harris-Kerr C; Pungliya MS; Alders M; Wilde AA; Ackerman MJ
    Circulation; 2009 Nov; 120(18):1752-60. PubMed ID: 19841300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brugada syndrome: clinical presentation and genotype-correlation with magnetic resonance imaging parameters.
    Rudic B; Schimpf R; Veltmann C; Doesch C; Tülümen E; Schoenberg SO; Borggrefe M; Papavassiliu T
    Europace; 2016 Sep; 18(9):1411-9. PubMed ID: 26511399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing.
    Ackerman MJ; Splawski I; Makielski JC; Tester DJ; Will ML; Timothy KW; Keating MT; Jones G; Chadha M; Burrow CR; Stephens JC; Xu C; Judson R; Curran ME
    Heart Rhythm; 2004 Nov; 1(5):600-7. PubMed ID: 15851227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of long QT syndrome-associated SCN5A variants in patients with early-onset lone atrial fibrillation.
    Olesen MS; Yuan L; Liang B; Holst AG; Nielsen N; Nielsen JB; Hedley PL; Christiansen M; Olesen SP; Haunsø S; Schmitt N; Jespersen T; Svendsen JH
    Circ Cardiovasc Genet; 2012 Aug; 5(4):450-9. PubMed ID: 22685113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy.
    Wilde AAM; Amin AS
    JACC Clin Electrophysiol; 2018 May; 4(5):569-579. PubMed ID: 29798782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.
    Liu J; Bayer JD; Aschar-Sobbi R; Wauchop M; Spears D; Gollob M; Vigmond EJ; Tsushima R; Backx PH; Chauhan VS
    PLoS One; 2018; 13(5):e0197273. PubMed ID: 29791480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilsicainide Administration Unmasks a Phenotype of Brugada Syndrome in a Patient with Overlap Syndrome due to the E1784K SCN5A Mutation.
    Hasebe H; Yokoya T; Murakoshi N; Kurebayashi N
    Intern Med; 2020 Jan; 59(1):83-87. PubMed ID: 31484910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic re-evaluation of SCN5A variants associated with Brugada syndrome.
    Denham NC; Pearman CM; Ding WY; Waktare J; Gupta D; Snowdon R; Hall M; Cooper R; Modi S; Todd D; Mahida S
    J Cardiovasc Electrophysiol; 2019 Jan; 30(1):118-127. PubMed ID: 30203441
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Kroncke BM; Glazer AM; Smith DK; Blume JD; Roden DM
    Circ Genom Precis Med; 2018 May; 11(5):e002095. PubMed ID: 29728395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic ajmaline challenge in patients with long QT 3 syndrome caused by the most common mutation: a multicentre study.
    Hohmann S; Rudic B; Konrad T; Duncker D; König T; Tülümen E; Rostock T; Borggrefe M; Veltmann C
    Europace; 2017 Oct; 19(10):1723-1729. PubMed ID: 27915266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sinus node dysfunction, Brugada syndrome and long QT syndrome affecting the same patient : when genetics can't make head or tail of it].
    Porretta AP; Davoine E; Superti-Furga A; Bhuiyan ZA; Domenichini G; Herrera Siklody C; Pascale P; Haddad C; Schläpfer J; Pruvot É
    Rev Med Suisse; 2020 Jun; 16(696):1148-1152. PubMed ID: 32496703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Clinical Manifestation of the Known SCN5A D1790G Mutation.
    Blich M; Efrati E; Marai I; Suleiman M; Gepstein L; Boulous M
    Cardiology; 2015; 132(4):228-32. PubMed ID: 26304620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation Load of Multiple Ion Channel Gene Mutations in Brugada Syndrome.
    Gualandi F; Zaraket F; Malagù M; Parmeggiani G; Trabanelli C; Fini S; Dang X; Wei X; Fang M; Bertini M; Ferrari R; Ferlini A
    Cardiology; 2017; 137(4):256-260. PubMed ID: 28494446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic and molecular basis for sodium channel-mediated Brugada syndrome].
    Barajas-Martínez H; Hu D; Antzelevitch C
    Arch Cardiol Mex; 2013; 83(4):295-302. PubMed ID: 24269159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.